Engineering a conditionally active cetuximab prodrug via affibody-based paratope masking
{{output}}
The application of monoclonal antibodies as targeted drugs has revolutionized cancer therapy, yet their efficacy is sometimes limited by toxicities arising from target expression in healthy tissues. Various strategies have emerged to overcome these issues, inc... ...